Combining several clinical studies, we propose that IL-18 not only accelerates the progression of atherosclerosis in CKD patients but also has a predictive value for cardiovascular prognosis in CKD patients (Sasaki et al., 2021). Here, IL18 is linked to atherosclerosis.